0000-0001-6781-7400 Employment
-
Pfizer (United States) Director, HTA, Value & Evidence2024 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (16)
- Development of the modified Daily Symptom Diary (mDSD): a patient-reported outcome measure of dysphagia for eosinophilic esophagitis Save
- Health State Utility is Substantially Reduced With an Increasing Burden of Patient-Reported Symptoms in Eosinophilic Esophagitis Save
- Healthcare Resource Utilization and Costs Associated With Eosinophilic Esophagitis Among Commercially Insured Patients in the United States Save
- <p>Efficacy and Safety of LAMA/LABA Fixed-Dose Combination Therapies in Chronic Obstructive Pulmonary Disease: A Systematic Review of Direct and Indirect Treatment Comparisons</p> Save
- Interventions based on early intensive applied behaviour analysis for autistic children: a systematic review and cost-effectiveness analysis Save
- Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β2-agonist fixed-dose combinations in COPD Save
- Relationship between health-related quality of life and respiratory health status among coal-based sponge iron plant workers in Barjora, India Save
- Ustekinumab for Treating Moderately to Severely Active Crohn’s Disease after Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Save
- Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation Save
- Crizotinib for Untreated Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Save